PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026JHEP Reports0 citationsOpen Access

Mass spectrometry-based de novo sequencing reveals non-canonical neoantigens with antitumor efficacy in hepatocellular carcinoma

View Full Paper
XXXiaohua XingMLMingxin LiuJOJiahe Ouyang

Key Points

Key points are not available for this paper at this time.

Abstract

BACKGROUND however, clinical translation beyond this preclinical murine model requires confirmation in human settings due to potential differences in HLA presentation and the tumor microenvironment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xing et al. (2026) studied this question.

synapsesocial.com/papers/6a1106ae6da82ae745f32f93https://doi.org/10.1016/j.jhepr.2026.101775
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.1996 · 294 citations
  2. 2Defining and Understanding Adaptive Resistance in Cancer Immunotherapy2018 · 197 citations
  3. 3Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development2022 · 11 citations
  4. 4Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation2024 · 18 citations
  5. 5Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoints2024 · 20 citations